Literature DB >> 29396264

Boosting, Not Breaking: CRISPR Activators Treat Disease Models.

Matthew Gemberling1, Charles A Gersbach2.   

Abstract

Mesh：

Year:  2018        PMID： 29396264      PMCID： PMC5835121          DOI： 10.1016/j.ymthe.2018.01.004

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  19 in total

1.  In Vivo Target Gene Activation via CRISPR/Cas9-Mediated Trans-epigenetic Modulation.

Authors:  Hsin-Kai Liao; Fumiyuki Hatanaka; Toshikazu Araoka; Pradeep Reddy; Min-Zu Wu; Yinghui Sui; Takayoshi Yamauchi; Masahiro Sakurai; David D O'Keefe; Estrella Núñez-Delicado; Pedro Guillen; Josep M Campistol; Cheng-Jang Wu; Li-Fan Lu; Concepcion Rodriguez Esteban; Juan Carlos Izpisua Belmonte
Journal:  Cell       Date:  2017-12-07       Impact factor: 41.582

2.  Activating human genes with zinc finger proteins, transcription activator-like effectors and CRISPR/Cas9 for gene therapy and regenerative medicine.

Authors:  Charles A Gersbach; Pablo Perez-Pinera
Journal:  Expert Opin Ther Targets       Date:  2014-06-11       Impact factor: 6.902

3.  Cas9 gRNA engineering for genome editing, activation and repression.

Authors:  Samira Kiani; Alejandro Chavez; Marcelle Tuttle; Richard N Hall; Raj Chari; Dmitry Ter-Ovanesyan; Jason Qian; Benjamin W Pruitt; Jacob Beal; Suhani Vora; Joanna Buchthal; Emma J K Kowal; Mohammad R Ebrahimkhani; James J Collins; Ron Weiss; George Church
Journal:  Nat Methods       Date:  2015-09-07       Impact factor: 28.547

Review 4.  Editing the epigenome: technologies for programmable transcription and epigenetic modulation.

Authors:  Pratiksha I Thakore; Joshua B Black; Isaac B Hilton; Charles A Gersbach
Journal:  Nat Methods       Date:  2016-02       Impact factor: 28.547

5.  Orthogonal gene knockout and activation with a catalytically active Cas9 nuclease.

Authors:  James E Dahlman; Omar O Abudayyeh; Julia Joung; Jonathan S Gootenberg; Feng Zhang; Silvana Konermann
Journal:  Nat Biotechnol       Date:  2015-11       Impact factor: 54.908

Review 6.  Genome-editing Technologies for Gene and Cell Therapy.

Authors:  Morgan L Maeder; Charles A Gersbach
Journal:  Mol Ther       Date:  2016-01-12       Impact factor: 11.454

7.  CRISPR-Cas9 epigenome editing enables high-throughput screening for functional regulatory elements in the human genome.

Authors:  Tyler S Klann; Joshua B Black; Malathi Chellappan; Alexias Safi; Lingyun Song; Isaac B Hilton; Gregory E Crawford; Timothy E Reddy; Charles A Gersbach
Journal:  Nat Biotechnol       Date:  2017-04-03       Impact factor: 54.908

8.  A protein-tagging system for signal amplification in gene expression and fluorescence imaging.

Authors:  Marvin E Tanenbaum; Luke A Gilbert; Lei S Qi; Jonathan S Weissman; Ronald D Vale
Journal:  Cell       Date:  2014-10-09       Impact factor: 41.582

9.  CRISPR RNA-guided activation of endogenous human genes.

Authors:  Morgan L Maeder; Samantha J Linder; Vincent M Cascio; Yanfang Fu; Quan H Ho; J Keith Joung
Journal:  Nat Methods       Date:  2013-07-25       Impact factor: 28.547

10.  RNA-guided gene activation by CRISPR-Cas9-based transcription factors.

Authors:  Pablo Perez-Pinera; D Dewran Kocak; Christopher M Vockley; Andrew F Adler; Ami M Kabadi; Lauren R Polstein; Pratiksha I Thakore; Katherine A Glass; David G Ousterout; Kam W Leong; Farshid Guilak; Gregory E Crawford; Timothy E Reddy; Charles A Gersbach
Journal:  Nat Methods       Date:  2013-07-25       Impact factor: 28.547
View more
  1 in total

1.  The transformational impact of site-specific DNA modifiers on biomedicine and agriculture.

Authors:  Kathryn Polkoff; Jorge A Piedrahita
Journal:  Anim Reprod       Date:  2018-08-16       Impact factor: 1.807
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.